Navigation Links
Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
Date:3/11/2008

These results provide Progen with confidence in the potential of PI-88 for this indication and we are therefore aggressively pursuing its development towards registration and commercialization.

About the phase 3 study: The phase 3 study investigating PI-88 as a post- resection treatment for hepatocellular carcinoma (HCC, primary liver cancer) following curative resection is a double-blinded, placebo-controlled study that has been designed to establish the efficacy and safety of PI-88 in the post-resection HCC setting. The trial will recruit approximately 600 patients at 65-70 hospitals in more than a dozen countries. Disease-free survival is the study's primary endpoint. Upon completion of this trial, the results are expected to form the basis of global regulatory filings for PI-88.

About Progen: Progen Pharmaceuticals is a globally focused biotechnology company committed to the discovery, development and commercialization of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has operations in Australia and the US.

Progen Information: Media and Investor Relations

Linton Burns Australia:

Progen Pharmaceuticals Limited Cindy Ingram

T: +61 7 3842 3333 Progen Pharmaceuticals Limited

E: lintonb@progen-pharma.com T: +61 7 3842 3333

E: cindyi@progen-pharma.com

Media Relations USA: Investor Relations USA:

Robert D. Stanislaro Evan Smith

Financial Dynamics Financial Dynamics

T: 212-850-5657 T: 212-850-5606

E: robert.stanislaro@fd.com E: evan.smith@fd.com

This press release contains forward-looking statements that are based on current management expectations. These statements
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
2. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
3. Progen Announces PI-88 Phase 2 Lung Cancer Results
4. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Inclinix Announces New Patent for Expert System Platform
7. Genzyme Announces Presentation of New Positive Data on Carticel(R)
8. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
9. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  PTC Therapeutics, Inc. (NASDAQ: ... a webcast conference call to report its second quarter ... company,s business and outlook on Thursday, August 7, 2014 ... market. The call can be accessed ... five minutes prior to the start of the call ...
(Date:7/24/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the first fiscal quarter ... , Revenues of $47.5 million, up 10% over ... $0.21, up 50% over last year,s comparable quarter. ... $7.2 million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... BUENA, N.J. , July 24, 2014 ... New Jersey based specialty generic pharmaceutical company, ... resignation from its Board of Directors.  Mr. Finio has ... company, and under the terms of his acceptance of ... continue in his role as Director for IGI Laboratories, ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... , July 30 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that on July ... LLC, stating that PharmAthene is not in compliance with the continued ... NYSE Amex Company Guide, because it has stockholders, equity of less ...
... 30 Conatus Pharmaceuticals Inc. announced today that Conatus ... disclosed.  Conatus Pharmaceuticals is a privately-held drug development company focused on liver ... , ... Ph.D., the former CEO of Idun Pharmaceuticals, which was acquired by Pfizer ...
Cached Medicine Technology:PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 2PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 3Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary 2
(Date:7/26/2014)... Louisville, Kentucky (PRWEB) July 26, 2014 ... concussions on the playing field; however, concussions ... on-the-job injuries. The occupations with the highest risk ... workers ,     Firefighters ,     Police officers ... dock workers ,     Delivery personnel ...
(Date:7/26/2014)... 2014 According to the "Get Rid ... is a comprehensive guide that provides readers with safe ... This book also teaches them how to fade dark ... in their own home for drastic results. , ... Naturally" book includes step-by-step tutorials and product recommendations for ...
(Date:7/25/2014)... Dental Perfection, a Derby cosmetic dentist that ... dentistry, clear braces and much more, has just announced ... Derby. The new practice, which is scheduled to open ... Littleover, Derby. Patients may already pre-register for the limited ... practice, which is headed by Invisalign specialist and cosmetic ...
(Date:7/25/2014)... 2014 Deep Research Report on ... Industry” is a professional and in-depth research report ... market. The report provides basic Laser Scanning Confocal ... definition, classification, application, and industry chain structure ... international market analysis, including China’s domestic market as ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 American motor ... or unexpected collisions can pay higher premiums for vehicle ... its local insurer network to provide SR22 insurance for ... , The different coverage network of local agencies ... expanded the search platform now publicly available for any ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2
... Ever dream of shifting around body fat to flatten ... Or maybe blocking that ample fat? According to ... reality. ,The study, published online in Nature ... treatment of diseases associated with human obesity," the Georgetown ...
... a unique opportunity for superstition and marketing to come together: ... and Live Earth concerts as well as the proclamation of ... ,"Number 7 has a magic sacred side and the ... sevens could bring an extra dose of good fortune. ...
... marketing authorization for INVEGA(TM) (paliperidone prolonged release ... treatment of schizophrenia. This once-daily medication ... the active ingredient in INVEGA - through ... clinical trials, INVEGA demonstrated significant efficacy as ...
... shown that female mice tend to create new brain cells ... that outlines how chemical messages may shape their choice of ... at the university looked at the effects of sex pheromones, ... choose their mates, on the brains of female mice. They ...
... studies have highlighted the adverse effects of computer games on ... can actually be good for children. ,According ... other give children a chance to learn about the opposite ... ,The study by researchers from Brunel University found ...
... have revealed that an 'early warning signal' in the brain ... discovered a mechanism in the brain that reacts in just ... errors in the past. ,Earlier research has ... initially make incorrect predictions than from things for which our ...
Cached Medicine News:Health News:Stressed Mice may Hold Clue to How Fat is Stored: Study 2Health News:A Lucky Number? 7/7/07 2Health News:A Lucky Number? 7/7/07 3Health News:INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia 2Health News:INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia 3Health News:INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia 4Health News:INVEGA Receives Marketing Authorization In EU For Treatment Of Schizophrenia 5Health News:Male Pheromones Build Brain Cells in Female Mice 2Health News:Exposure to Computer Games can Be 'good' for Kids, Says New Study 2Health News:This is How We Learn from Our Past Mistakes 2
... is a sterile, pre-shaped, three-dimensional device constructed ... mesh cylinder to a circular underlay patch.,The ... and innovative design combines the three most ... the repair of inguinal hernias. ,Its Onlay ...
Surgisis Inguinal Hernia Matrix is implanted to reinforce soft tissues in the inguinal floor to repair inguinal hernias. Supplied sterile in peel-open packages. Intended for one-time use....
... Gemini is the newest addition to Laserscopes ... distinct wavelengths to choose from, 1064nm Nd:YAG ... in an exploding non-invasive aesthetic laser market ... and effectiveness while maintaining the safety and ...
... of 532 nm lasers are distinguished from ... solid-state design. A compact and sealed ... and reliable for a broad range of ... hemoglobin and an adjustable pulse length, the ...
Medicine Products: